Israel Active

Israel’s InSightec Ltd. today reported success in a clinical trial of its noninvasive focused ultrasound ExAblate Neuro system to treat chronic neurological disorders.

At least 200 medical clowns from America, Europe and Australia will attend the October convention. Dream Doctors, funded by Magi Foundation, helped set up the world's only undergraduate degree program in clown therapy as a paramedical profession at the University of Haifa.

Father and son, Yehuda and Israel Pilosof, work around the clock making prosthetic limbs for survivors of disasters such as the Haiti earthquake. Their life motto is “make possible what is impossible”.

Israel’s BioProtect has developed a biodegradable balloon that creates a physical separation between tumours and healthy tissues during radiation therapy, reducing damage to healthy tissue.

Israel’s CureTech Ltd. announced the final successful results of its Phase II clinical trial of CT-011 stem cell treatment of Diffuse Large B Cell Lymphoma.

Israeli biotech Pluristem Therapeutics has announced that initial animal studies found that its placental stem cells can treat Acute Radiation Syndrome (ARS).

Construction of the new 14-storey hospital building is complete. It will replace the current 50 year-old round building, which will become Hadassah’s research and admin centre.

Ben Gurion University researchers have identified a mutation of the gene LEPREL1 by studying a Bedouin tribe where the defect is the cause of hereditary myopia.

Israel biotech WideMed has obtained US Food and Drug Administration (FDA) approval for its sleep apnea monitoring system, Morpheus Ox, for home use.

Israeli scientist Dr. Inbar Friedrich Ben-Nun is leading a US team that has produced the first stem cells from endangered species and could save animals from extinction. This report was also broadcast on BBC World Service – without mentioning that the lead scientist was Israeli!